These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 35222270)

  • 1. The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms.
    Zhu B; Qu S
    Front Endocrinol (Lausanne); 2022; 13():800995. PubMed ID: 35222270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.
    Onitilo AA; Engel JM; Glurich I; Stankowski RV; Williams GM; Doi SA
    Cancer Causes Control; 2012 Jul; 23(7):991-1008. PubMed ID: 22527174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.
    Suh S; Kim KW
    Diabetes Metab J; 2019 Dec; 43(6):733-743. PubMed ID: 31902143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia in Obesity, Inflammation, and Cancer.
    Zhang AMY; Wellberg EA; Kopp JL; Johnson JD
    Diabetes Metab J; 2021 May; 45(3):285-311. PubMed ID: 33775061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and cancer: a 2013 synopsis.
    Buysschaert M; Sadikot S
    Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profile.
    Schwartz SS; Jellinger PS; Herman ME
    Postgrad Med; 2016 Aug; 128(6):609-19. PubMed ID: 27210018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and Cancer: The Epidemiological and Metabolic Associations.
    Zhang C; Le A
    Adv Exp Med Biol; 2021; 1311():217-227. PubMed ID: 34014546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus type 2 - an independent risk factor for cancer?
    Grote VA; Becker S; Kaaks R
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes and Cancer: An Overview of Epidemiological Evidence and Potential Mechanisms.
    Mirmiran P; Bahadoran Z; Ghasemi A; Hosseinpanah F
    Crit Rev Oncog; 2019; 24(3):223-233. PubMed ID: 32422020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
    Giovannucci E; Michaud D
    Gastroenterology; 2007 May; 132(6):2208-25. PubMed ID: 17498513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interlinking of diabetes mellitus and cancer: An overview.
    Ahmad I; Suhail M; Ahmad A; Alhosin M; Tabrez S
    Cell Biochem Funct; 2023 Jul; 41(5):506-516. PubMed ID: 37199325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association.
    Diabetes Care; 1995 Nov; 18(11):1510-8. PubMed ID: 8722084
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus and cancer risk: review of the epidemiological evidence.
    Shikata K; Ninomiya T; Kiyohara Y
    Cancer Sci; 2013 Jan; 104(1):9-14. PubMed ID: 23066889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Insulin Resistance on Cardiovascular Control During Exercise in Diabetes.
    Mizuno M; Hotta N; Ishizawa R; Kim HK; Iwamoto G; Vongpatanasin W; Mitchell JH; Smith SA
    Exerc Sport Sci Rev; 2021 Jul; 49(3):157-167. PubMed ID: 33965976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes as a risk factor to cancer: functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer.
    Aruoma OI; Somanah J; Bourdon E; Rondeau P; Bahorun T
    Mutat Res; 2014 Oct; 768():60-8. PubMed ID: 24769427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.
    Lee Y; Berglund ED; Yu X; Wang MY; Evans MR; Scherer PE; Holland WL; Charron MJ; Roth MG; Unger RH
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13217-22. PubMed ID: 25157166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLUT4 degradation by GLUTFOURINH® in mice resembles moderate-obese diabetes of human with hyperglycemia and low lipid accumulation.
    Lee SR; Jeong SH; Mukae M; Jeong KJ; Kwun HJ; Hong EJ
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166668. PubMed ID: 36822448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
    Carstensen B
    Diabetes; 2010 Sep; 59(9):e17-8; author reply e19-22. PubMed ID: 20805379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.